GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
1-Year Return
49.13%
This Quarter Return
+6.3%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$342M
AUM Growth
-$31.8M
(-8.5%)
Cap. Flow
-$54.2M
Cap. Flow
% of AUM
-15.86%
Top 10 Holdings %
Top 10 Hldgs %
37.58%
Holding
84
New
21
Increased
8
Reduced
21
Closed
21
Top Buys
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$12.5M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$12.3M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$12.2M |
| 4 |
ENDP
Endo International plc
ENDP
|
$8.38M |
| 5 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$8.22M |
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$12.7M |
| 2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$9.86M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$9.84M |
| 4 |
Merck
MRK
|
$9.53M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$9.42M |
Sector Composition
| 1 | Healthcare | 82.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
26
DELISTED
NanoString Technologies, Inc.
NSTG
| $5.79M | 1.2% |
350,000
-50,000
| -13% | -$827K |
|
27
Gilead Sciences
GILD
$142B
| $5.31M | 1.1% |
+75,000
| New | +$5.31M |
|
|
AIMT
28
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $5.14M | 1.07% |
+250,000
| New | +$5.14M |
|
29
Atara Biotherapeutics
ATRA
$89.1M
| $4.9M | 1.02% |
+14,000
| New | +$4.9M |
|
|
VRAY
30
DELISTED
ViewRay, Inc.
VRAY
| $4.85M | 1.01% |
+750,000
| New | +$4.85M |
|
31
Boston Scientific
BSX
$158B
| $4.85M | 1.01% |
175,000
-275,000
| -61% | -$7.62M |
|
32
Neurogene
NGNE
$285M
| $4.22M | 0.88% |
15,000
+3,750
| +33% | +$1.06M |
|
33
argenx
ARGX
$45.8B
| $4.16M | 0.87% |
+196,287
| New | +$4.16M |
|
|
SIOX
34
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $4.06M | 0.84% |
+21,875
| New | +$4.06M |
|
35
Iovance Biotherapeutics
IOVA
$861M
| $4.04M | 0.84% |
550,000
-650,000
| -54% | -$4.78M |
|
|
SAGE
36
DELISTED
Sage Therapeutics
SAGE
| $3.98M | 0.83% |
50,000
-50,000
| -50% | -$3.98M |
|
37
BioCryst Pharmaceuticals
BCRX
$1.73B
| $3.75M | 0.78% |
675,000
-825,000
| -55% | -$4.59M |
|
|
CBAY
38
DELISTED
Cymabay Therapeutics
CBAY
| $3.74M | 0.78% |
650,000
+150,000
| +30% | +$864K |
|
39
PTC Therapeutics
PTCT
$4.59B
| $3.67M | 0.76% |
200,000
| – | – |
|
|
KTWO
40
DELISTED
K2M Group Holdings, Inc
KTWO
| $3.65M | 0.76% |
150,000
-135,000
| -47% | -$3.29M |
|
|
NEOS
41
DELISTED
Neos Therapeutics, Inc
NEOS
| $3.65M | 0.76% |
+500,000
| New | +$3.65M |
|
|
BPMC
42
DELISTED
Blueprint Medicines
BPMC
| $3.55M | 0.74% |
70,000
-30,000
| -30% | -$1.52M |
|
43
Rigel Pharmaceuticals
RIGL
$727M
| $3M | 0.62% |
110,000
| – | – |
|
|
ALDR
44
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $2.86M | 0.6% |
+250,000
| New | +$2.86M |
|
45
Syndax Pharmaceuticals
SNDX
$1.45B
| $2.79M | 0.58% |
+200,000
| New | +$2.79M |
|
|
XLRN
46
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.74M | 0.57% |
90,000
-310,000
| -78% | -$9.42M |
|
|
ITCI
47
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.48M | 0.52% |
200,000
+50,000
| +33% | +$621K |
|
48
IRIDEX
IRIX
$24.3M
| $2.47M | 0.51% |
250,000
| – | – |
|
|
RVNC
49
DELISTED
Revance Therapeutics, Inc.
RVNC
| $2.36M | 0.49% |
+89,295
| New | +$2.36M |
|
|
EPZM
50
DELISTED
Epizyme, Inc
EPZM
| $2.27M | 0.47% |
150,000
-450,000
| -75% | -$6.8M |
|